Literature DB >> 10660045

Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion.

D Raucher1, T Stauffer, W Chen, K Shen, S Guo, J D York, M P Sheetz, T Meyer.   

Abstract

Binding interactions between the plasma membrane and the cytoskeleton define cell functions such as cell shape, formation of cell processes, cell movement, and endocytosis. Here we use optical tweezers tether force measurements and show that plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP2) acts as a second messenger that regulates the adhesion energy between the cytoskeleton and the plasma membrane. Receptor stimuli that hydrolyze PIP2 lowered adhesion energy, a process that could be mimicked by expressing PH domains that sequester PIP2 or by targeting a 5'-PIP2-phosphatase to the plasma membrane to selectively lower plasma membrane PIP2 concentration. Our study suggests that plasma membrane PIP2 controls dynamic membrane functions and cell shape by locally increasing and decreasing the adhesion between the actin-based cortical cytoskeleton and the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660045     DOI: 10.1016/s0092-8674(00)81560-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  239 in total

1.  Rapid stiffening of integrin receptor-actin linkages in endothelial cells stimulated with thrombin: a magnetic bead microrheology study.

Authors:  A R Bausch; U Hellerer; M Essler; M Aepfelbacher; E Sackmann
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

2.  Distinct effect of actin cytoskeleton disassembly on exo- and endocytic events in a membrane patch of rat melanotrophs.

Authors:  Helena H Chowdhury; Marko Kreft; Robert Zorec
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

3.  The yeast inositol polyphosphate 5-phosphatases inp52p and inp53p translocate to actin patches following hyperosmotic stress: mechanism for regulating phosphatidylinositol 4,5-bisphosphate at plasma membrane invaginations.

Authors:  L M Ooms; B K McColl; F Wiradjaja; A P Wijayaratnam; P Gleeson; M J Gething; J Sambrook; C A Mitchell
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 4.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

5.  The C2A domain of JFC1 binds to 3'-phosphorylated phosphoinositides and directs plasma membrane association in living cells.

Authors:  Sergio D Catz; Jennifer L Johnson; Bernard M Babior
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

6.  Agonist-induced PIP(2) hydrolysis inhibits cortical actin dynamics: regulation at a global but not at a micrometer scale.

Authors:  Jacco van Rheenen; Kees Jalink
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

7.  Physical mobilization of secretory vesicles facilitates neuropeptide release by nerve growth factor-differentiated PC12 cells.

Authors:  Yuen-Keng Ng; Xinghua Lu; Edwin S Levitan
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

8.  Abnormal bradykinin signalling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1.

Authors:  S F Suchy; J C Cronin; R L Nussbaum
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

9.  Expression of phosphatidylinositol (4,5) bisphosphate-specific pleckstrin homology domains alters direction but not the level of axonal transport of mitochondria.

Authors:  Kurt J De Vos; Julia Sable; Kyle E Miller; Michael P Sheetz
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

10.  The phosphoinositide phosphatase Sac1 regulates cell shape and microtubule stability in the developing Drosophila eye.

Authors:  Lauren M Del Bel; Nigel Griffiths; Ronit Wilk; Ho-Chun Wei; Anastasia Blagoveshchenskaya; Jason Burgess; Gordon Polevoy; James V Price; Peter Mayinger; Julie A Brill
Journal:  Development       Date:  2018-05-31       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.